Invesaro

Stocks Comparison

Cencora vs Cosmos Health: revenue, profit, margins and growth compared

Cencora brought in $321.3B of revenue in fiscal 2025, Cosmos Health $65.3M in fiscal 2025. Revenue changed by +9.3% at Cencora and +19.9% at Cosmos Health on the year before, so Cosmos Health grew faster. Cencora kept 0.5% of its revenue as net profit, Cosmos Health -29.3%. Free cash flow was $3.2B at Cencora and -$8.5M at Cosmos Health.

Side by side, latest fiscal year

CORCOSM
Fiscal year endedFY2025 (September 30, 2025)FY2025 (December 31, 2025)
Revenue$321.3B$65.3M
Revenue growth+9.3%+19.9%
Net income$1.6B-$19.1M
Net margin0.5%-29.3%
Free cash flow$3.2B-$8.5M
Free cash flow margin1.0%-13.0%
Earnings per share (diluted)$7.96-$0.63
Cash$4.4B$715.7K
Debt$7.7B$3.8M
Price to earnings38.6n/a
Market value$58.6B$21.8M
Dividend yield0.72%n/a
Rank by revenue in sector#3 of 646 · Health care#353 of 646 · Health care

Over the years

Revenue
COR FY2018: $167.9BCOR FY2019: $179.6BCOR FY2020: $189.9BCOR FY2021: $214BCOR FY2022: $238.6BCOR FY2023: $262.2BCOR FY2024: $294BCOR FY2025: $321.3BCOSM FY2018: $37.1MCOSM FY2019: $39.7MCOSM FY2020: $55.4MCOSM FY2021: $56.2MCOSM FY2022: $50.3MCOSM FY2023: $53.4MCOSM FY2024: $54.4MCOSM FY2025: $65.3MFY18FY19FY20FY21FY22FY23FY24FY25
COR $321.3BCOSM $65.3M
Net income
COR FY2018: $1.7BCOR FY2019: $855.4MCOR FY2020: -$3.4BCOR FY2021: $1.5BCOR FY2022: $1.7BCOR FY2023: $1.7BCOR FY2024: $1.5BCOR FY2025: $1.6BCOSM FY2018: -$9.1MCOSM FY2019: -$3.3MCOSM FY2020: $820.8KCOSM FY2021: -$8MCOSM FY2022: -$13.8MCOSM FY2023: -$18.5MCOSM FY2024: -$16.2MCOSM FY2025: -$19.1MFY18FY19FY20FY21FY22FY23FY24FY25
COR $1.6BCOSM -$19.1M
Net margin
COR FY2018: 1.0%COR FY2019: 0.5%COR FY2020: -1.8%COR FY2021: 0.7%COR FY2022: 0.7%COR FY2023: 0.7%COR FY2024: 0.5%COR FY2025: 0.5%COSM FY2018: -24.4%COSM FY2019: -8.3%COSM FY2020: 1.5%COSM FY2021: -14.2%COSM FY2022: -27.5%COSM FY2023: -34.7%COSM FY2024: -29.7%COSM FY2025: -29.3%FY18FY19FY20FY21FY22FY23FY24FY25
COR 0.5%COSM -29.3%
Revenue growth
COR FY2019: +6.9%COR FY2020: +5.7%COR FY2021: +12.7%COR FY2022: +11.5%COR FY2023: +9.9%COR FY2024: +12.1%COR FY2025: +9.3%COSM FY2019: +7.0%COSM FY2020: +39.6%COSM FY2021: +1.5%COSM FY2022: -10.5%COSM FY2023: +6.0%COSM FY2024: +2.0%COSM FY2025: +19.9%FY19FY20FY21FY22FY23FY24FY25
COR +9.3%COSM +19.9%
Free cash flow
COR FY2018: $1.1BCOR FY2019: $2BCOR FY2020: $1.8BCOR FY2021: $2.2BCOR FY2022: $2.2BCOR FY2023: $3.5BCOR FY2024: $3BCOR FY2025: $3.2BCOSM FY2018: -$2.1MCOSM FY2020: -$11.6MCOSM FY2021: -$7.7MCOSM FY2022: -$14.9MCOSM FY2023: -$16.9MCOSM FY2024: -$8.1MCOSM FY2025: -$8.5MFY18FY19FY20FY21FY22FY23FY24FY25
COR $3.2BCOSM -$8.5M

Fiscal years as each company reports them; the two may end in different months.

Questions about Cencora and Cosmos Health

Which is bigger by revenue, Cencora or Cosmos Health?

Cencora is bigger by revenue: $321.3B in fiscal 2025, against $65.3M for Cosmos Health in fiscal 2025.

Which keeps more of its revenue as profit, Cencora or Cosmos Health?

Cencora had a net margin of 0.5% in fiscal 2025; Cosmos Health had -29.3% in fiscal 2025.

Which grew revenue faster, Cencora or Cosmos Health?

In their latest fiscal years revenue changed by +9.3% at Cencora and +19.9% at Cosmos Health.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies